Home Newsfeeds Wedbush Maintains Outperform on Tesla, Adjusts Price Target to $360 – 3-for-1 Stock Split

Wedbush Maintains Outperform on Tesla, Adjusts Price Target to $360 – 3-for-1 Stock Split

Wedbush analyst Daniel Ives maintains Tesla (NASDAQ:TSLA) with a Outperform, adjusts price target to $360 – 3-for-1 stock split.

byBenzinga Newsdesk

August 25, 2022

1 minute read

Wedbush analyst Daniel Ives maintains Tesla (NASDAQ:TSLA) with a Outperform, adjusts price target to $360 – 3-for-1 stock split.

News

eFFECTOR Therapeutics To Collaborate With The Northwestern University Division Of Hematology And Oncology On An Investigator-Initiated Phase 1 Dose Escalation Trial Evaluating Tomivosertib In Patients With Acute Myeloid Leukemia

By Benzinga Newsdesk

October 24, 8:19 AM

eFFECTOR Therapeutics, Inc. (NASDAQ:EFTR), a leader in the development of selective translation regulator inhibitors (STRIs) for the treatment of cancer, today announced the initiation of dosing in an

EFTR

News

Biden Administration Denies Cheniere Request To Exempt LNG Gas Turbines From Pollution Rule

By Benzinga Newsdesk

September 6, 4:23 PM

- Reuters

LNG

News

‘TSMC, UMC Stick To Plans For Price Increases In 2023’ – DigiTimes

By Benzinga Newsdesk

November 1, 11:51 AM

IC design houses have failed to negotiate lower foundry quotes for 2023 with TSMC and United Microelectronics (UMC), as both foundries stick to their plans for price increases next year, according to industry sources.

TSM